Role of Bacteriophages in the Evolution of Pathogenic Vibrios and Lessons for Phage Therapy
February 16, 2023
Roberto C Molina-Quiroz, Andrew Camilli, Cecilia A Silva-Valenzuela
Low frequency of allergy referral for penicillin allergy evaluation in an urban Boston primary care setting
February 6, 2023
Alysse G. Wurcel, MD, MS, Rubeen Guardado, BA, MPH, Christina Ortiz, BS, Charles R. Bornmann, MD, Joseph Gillis, BA, Kristin Huang, MD, Shira Doron, MD, MS, Maureen Campion, PharmD, Kimberly G. Blumenthal, MD, MSc
Characterization of a Novel Pathogen in Immunocompromised Patients: Elizabethkingia anophelis—Exploring the Scope of Resistance to Contemporary Antimicrobial Agents and β-lactamase Inhibitors
February 1, 2023
Mohamad Yasmin, Laura J Rojas, Steven H Marshall, Andrea M Hujer, Anna Cmolik, Emma Marshall, Helen W Boucher, Alejandro J Vila, Maxime Soldevila, Seydina M Diene, Jean-Marc Rolain, Robert A Bonomo
One Health interprofessional stewardship to combat antimicrobial resistance
January 19, 2023
Amy M. Sjoberg, Claire L. Fellman, Ian M. DeStefano, Sarah M. Langfitt, Madeleine R. Stein, Manlik Kwong, Kirthana Beaulac & Shira Doron
Impact of antimicrobial use in dogs on antimicrobial resistance and shared flora with human owners
January 9, 2023
Kirthana Beaulac , Claire L Fellman , Annie S Wayne, Laura A McDermott , David R Snydman, Shira Doron
Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis
January 6, 2023
Talia Greenstein, Bree B. Aldridge
Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial
January 6, 2023
Michael W Dunne, Steven I Aronin, Anita F Das, Karthik Akinapelli, Michael T Zelasky, Sailaja Puttagunta, Helen W Boucher
Advances in the design of combination therapies for the treatment of tuberculosis
December 28, 2022
Jonah Larkins-Ford, Bree B. Aldridge
Tuberculosis treatment failure associated with evolution of antibiotic resilience
December 9, 2022
Qingyun Liu, Junhao Zhu , Charles L Dulberger , Sydney Stanley, Sean Wilson, Eun Seon Chung, Xin Wang, Peter Culviner, Yue J Liu, Nathan D Hicks, Gregory H Babunovic, Samantha R Giffen, Bree B Aldridge, Ethan C Garner, Eric J Rubin, Michael C Chao, Sarah M Fortune
Design principles to assemble drug combinations for effective tuberculosis therapy using interpretable pairwise drug response measurements
September 8, 2022
Jonah Larkins-Ford, Yonatan N. Degefu, Nhi Van, Artem Sokolov, Bree B. Aldridge
- Strain diversity drives heterogeneous responses to tuberculosis combination therapyMay 15, 2026
- A New Era for Global Environmental Surveillance of Infectious DiseaseApril 30, 2026
- Restoration of daptomycin sensitivity with adjunctive cefazolin is associated with C-terminal MprF mutations in MRSA bacteremia isolatesApril 27, 2026
- An RNA-to-RNA Pipeline for Rapid Antiviral Antibody DevelopmentApril 9, 2026
- Antibiotic dose-response curves can measure antibiotic activity against Mycobacterium abscessus and Mycobacterium peregrinumApril 6, 2026